Genomic & Biopharma News

Exosomes in perspective – a potential surrogate for stem cell therapy
Exosomes as a unique subtype of small extracellular vesicles (sEVs) have attracted increasing interest in recent years in the fields of mesenchymal stromal...
Exosome RNA Research & Industry News, 2018-10-18 11:00:22

Paired-cell RNA sequencing enables spatial gene expression mapping of liver endothelial cells
Spatially resolved single-cell RNA sequencing (scRNAseq) is a powerful approach for inferring connections between a cell's identity and its position in a tissue. Researchers at the Weizmann Institute of Science recently combined scRNAseq with spatially...
Transcriptome Research & Industry News, 2018-10-18 11:00:13

AI pathology diagnostic tool developed using deep learning technology from Olympus
Since 2017, Olympus Corporation has participated in a joint research program that has the potential to help streamline the workload of clinical pathologists, called “A New Approach to Develop Computer-Aided Diagnosis Using Artificial Intelligence (AI) for Gastric Biopsy Specimens”.
News Medical Life Sciences, 2018-10-18 10:56:52

Harnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals.  For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
ORB Company Blog, 2017-03-31 21:41:45

Gilead, Aelix ally to trial HIV-suppressing combination
Gilead has teamed up with Aelix Therapeutics to trial a combination designed to free people with HIV from the need to take antiretroviral drugs. The planned clinical trial will test Gilead’s TLR7 agonist in combination with Aelix’s T-cell vaccine. 
Fierce Biotech, 2018-10-18 10:38:27

Gov’t to introduce tech standards for the NHS
Health secretary Matt Hancock has unveiled his vision for technology in healthcare, which, he claims, will lay the foundation for a new generation of digital services able to meet the needs of clinicians, patients and managers.
PharmaTimes, 2018-10-18 10:27:49

Molding bacteria into unnatural shapes reveals the robustness of cell division
Researchers at OIST have shown that microbes can be molded into an array of unusual, elaborate shapes that are not seen in nature.
News Medical Life Sciences, 2018-10-18 10:00:00

Novartis inks $2.1B Endocyte buyout, furthering radiotherapy push
Novartis has struck a $2.1 billion (€1.8 billion) deal to acquire Endocyte. The deal caps off a whirlwind year for Endocyte, which licensed the cancer drug that caught Novartis’ eye for $12 million just 12 months ago.
Fierce Biotech, 2018-10-18 09:55:05

NHS green light for Novartis skin cancer combo
The NHS now has three months to ensure that Novartis’ combination therapy dabrafenib/trametinib is routinely available to eligible skin cancer patients, after cost regulators published guidance backing funds for the treatment.
PharmaTimes, 2018-10-18 09:51:19

Harnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals.  For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
ORB Company Blog, 2017-03-31 21:41:45

Allergan to file ubrogepant for migraine early next year
Allergan is gearing up to file its oral CGRP receptor ubrogepant in the US for the treatment of migraine, following the success and completion of two safety studies.
PharmaTimes, 2018-10-18 09:38:17